Among patients with heart failure and reduced ejection fraction (HFrEF), those taking a “polypill” combination of three medications typically prescribed for heart failure, once daily for six months, ...
A once-daily polypill containing 3 guideline-directed therapies for heart failure with reduced ejection fraction (HFrEF) led ...
According to the American College of Cardiology, nearly 6.7 million Americans have heart failure, more than half with preserved ejection fraction. This condition often leads to frequent ...
A polypill containing three recommended heart failure therapies improved heart function, reduced hospitalizations and was ...
News Medical on MSN
Single daily polypill improves heart function and quality of life in heart failure patients
Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for the treatment of heart failure, had improved heart function and symptoms, ...
New findings reveal sotagliflozin's benefits for patients with heart failure with preserved ejection fraction without ...
Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback